Nanocarriers Boosted Podophyllotoxin Cancer Treatment
Researchers demonstrated that a specialized lipid carrier system enhanced the tumor-fighting efficacy of podophyllotoxin in mice.
Updated on Sept. 28, 2026 in Cancer

Live Poll
Do you believe nanotechnology advances will lead to more effective cancer treatment options for patients?
A laboratory study found that encapsulating podophyllotoxin in nanostructured lipid carriers significantly improved its ability to inhibit tumor growth. Treated mice experienced tumor size reductions of up to 82.8% over a two-week period.
Why it matters
The research aimed to overcome the limitations of free podophyllotoxin, specifically its poor bioavailability and systemic toxicity, to develop more effective cancer treatment methods. This delivery system showed potential for enhancing anticancer efficacy while managing tumor progression through molecular pathways.
Researchers tested dosages of 1, 1.5, and 2 mg/kg over a 14-day period. The observed reduction in tumor size ranged from 51.9% to 82.8% compared to the control.
The details
The delivery system utilized newly synthesized nanostructured lipid carriers to encapsulate the drug, which researchers evaluated using biochemical assays, qRT-PCR, and immunohistochemistry. The treatment successfully modulated key proteins, upregulating P53 and cytochrome c while downregulating NF-κB and Nrf-2, effectively inducing DNA damage in tumor tissues.
Timeline
The treatment period for the study lasted 14 days.
The Big Picture
This study follows a pattern set by research into nanostructured lipid carrier drug delivery systems by demonstrating increased therapeutic outcomes in malignant tissue.
These findings provide a foundation for potentially improving the safety and efficacy of future chemotherapy drugs. This development could eventually lead to treatments that minimize systemic toxicity while maintaining high effectiveness against tumors.
The takeaway
By utilizing nanotechnology to improve drug delivery, researchers can significantly increase the potency of established compounds. This approach highlights the importance of carrier systems in optimizing medical treatments and reducing the negative side effects of powerful drugs.
Further reading
Learn more about the latest developments in Cancer research on our dedicated hub.
Live Poll
Do you believe nanotechnology advances will lead to more effective cancer treatment options for patients?







